Metastatic malignant neoplasm in the spinal cord
disease diseaseOn this page
Also known as metastasis to spinal cordMetastatic malignant neoplasm to the spinal cordMetastatic neoplasm to the spinal cordMetastatic tumor to the spinal cordMetastatic tumour to the spinal cordSecondary malignant neoplasm to the spinal cordSecondary malignant tumor to the spinal cordSecondary malignant tumour to the spinal cord
Summary
Metastatic malignant neoplasm in the spinal cord (MONDO:0044912) is a cancer and 1 clinical trial. Top therapeutic interventions include doxepin hydrochloride. A subtype of spinal cord cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Clinical trials: 1
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | metastatic malignant neoplasm in the spinal cord |
| Mondo ID | MONDO:0044912 |
| NCIT | C4585 |
| SNOMED CT | 94600009 |
| UMLS | C0347016 |
| MedGen | 138075 |
| GARD | 0027980 |
| Anatomy (UBERON) | UBERON:0002240 |
| Is cancer (heuristic) | yes |
Also known as: metastasis to spinal cord · Metastatic malignant neoplasm in the spinal cord · Metastatic malignant neoplasm to the spinal cord · Metastatic neoplasm to the spinal cord · Metastatic tumor to the spinal cord · Metastatic tumour to the spinal cord · Secondary malignant neoplasm to the spinal cord · Secondary malignant tumor to the spinal cord · Secondary malignant tumour to the spinal cord
Disease family
This is a subtype of spinal cord cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › nervous system cancer › central nervous system cancer › spinal cord cancer › metastatic malignant neoplasm in the spinal cord
Related subtypes (7): spinal cord lymphoma, spinal cord melanoma, spinal cord sarcoma, spinal cord glioma, spinal cord neuroblastoma, spinal meninges cancer, spinal cord primitive neuroectodermal tumor
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02062632 | PHASE2 | TERMINATED | Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| DOXEPIN HYDROCHLORIDE | 4 | 1 |
| CHEMBL1200462 | 0 | 1 |
Related Atlas pages
- Drugs: Doxepin